183490 — Enzychem Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Market Cap
KR₩90bn
Enterprise Value
-KR₩14bn
Revenue
KR₩77bn

Annual balance sheet for Enzychem Lifesciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	90,504	94,587	192,856	137,226	116,776
Net Total Accounts Receivable
Net Total Receivables	4,786	6,107	10,510	21,362	18,480
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	104,999	109,783	220,313	174,475	148,230
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15,669	15,431	23,294	26,164	24,160
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	123,802	133,084	247,555	211,546	181,744
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9,784	53,621	42,284	14,154	11,375
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	51,320	58,422	45,811	18,030	21,391
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	72,483	74,662	201,744	193,516	160,353
Total Liabilities & Shareholders' Equity	123,802	133,084	247,555	211,546	181,744
Total Common Shares Outstanding
Total Preferred Shares Outstanding